US BROKER MOVES: MA upgraded at BNPP; MU downgraded at Summit Insights

UPGRADES

Carnival (CCL) Upgraded from Equalweight to Overweight W/ USD 31.00 PT (prev. USD 33.00) at Morgan Stanley
Cross Country Healthcare (CCRN) Upgraded from Neutral to Outperform W/ USD 15.00 PT (prev. USD 11.00) at Wedbush
Five Below (FIVE) Upgraded from Market Perform to Outperform at William Blair
Fluence Energy (FLNC) Upgraded from Sell to Neutral at Guggenheim
Kohl’s (KSS) Upgraded from Reduce to Buy W/ USD 20.00 PT at Gordon Haskett
Mastercard (MA) Upgraded from Neutral to Outperform W/ USD 600.00 PT at BNP Paribas Exane
MoonLake Immunotherapeutics (MLTX) Upgraded from Neutral to Buy W/ USD 40.00 PT (prev. USD 12.00) at Rothschild Redburn
Nu Holdings (NU) Upgraded from Neutral to Buy W/ USD 17.60 PT (prev. USD 17.20) at UBS
SouthState Corporation (SSB) Upgraded from Market Perform to Outperform at Hovde Group
Union Pacific (UNP) Upgraded from In Line to Outperform W/ USD 262.00 PT (prev. USD 260.00) at Evercore ISI

DOWNGRADES

CSX (CSX) Downgraded from Outperform to In Line W/ USD 41.00 PT (prev. USD 40.00) at Evercore ISI
Freshworks (FRSH) Downgraded from Outperform to Perform at Oppenheimer
Kinsale Capital Group (KNSL) Downgraded from Hold to Underperform W/ USD 312.00 PT (prev. USD 392.00) at Jefferies
Micron Technology (MU) Downgraded from Buy to Hold at Summit Insights
Xponential Fitness (XPOF) Downgraded from Strong Buy to Market Perform at Raymond James

INITIATIONS

Aligos Therapeutics (ALGS) Initiated Buy W/ USD 48.00 PT at Jefferies
ALX Oncology (ALXO) Initiated Overweight W/ USD 5.00 PT at Wells Fargo
EnerSys (ENS) Initiated Buy W/ USD 190.00 PT at TD Cowen
Okta (OKTA) Initiated Outperform W/ USD 100.00 PT at Macquarie
Olema Pharmaceuticals (OLMA) Initiated Buy W/ USD 40.00 PT at Jefferies
Companhia de Saneamento Básico do Estado de São Paulo (SBS) Initiated Buy W/ USD 36.60 PT at Jefferies
Vor Biopharma (VOR) Initiated Overweight W/ USD 30.00 PT at Wells Fargo